Claude isn't the most feature-rich AI chatbot, but it performs most tasks reasonably well and benefits from a well-designed ...

Visual charts help patterns and trends stand out faster than raw numbers alone.Different visualization types suit different ...

These obscure charts might be the key to visualizing your data.

Spotlighting Dr. Ida Rolf’s Overlooked Legacy and the Origins of Structural Integration - Decades Before Fascia Became ...

As Microsoft ramps up Copilot’s capabilities in Excel, the AI tool is becoming genuinely useful for spreadsheet work.

Once data is loaded into Excel, Copilot allows users to ask questions in natural language instead of building new formulas.

ORR was 50% in patients treated with MDNA11 in 2L/3L setting and 42% when MDNA11 was the next treatment post-ICI failure, showing best-in-class potential for ...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--The first patient has been dosed in the randomization phase of the DESTINY-Ovarian01 phase 3 trial evaluating ENHERTU ® (trastuzumab deruxtecan) in ...

And just this past week against Pittsburgh, the offensive line had an 85% pass block win rate (second highest mark of the season) and a 22% pressure rate allowed (lowest Caleb Williams has faced all ...

In August, Zongertinib received FDA approval for previously treated HER2-mutant NSCLC. It now shows efficacy in first-line treatment, with a 77% objective response rate and 96% disease control rate.

Zepzelca (lurbinectedin) is a chemotherapy medicine that damages the DNA of cancer cells by disrupting their protein function and ability to repair DNA. This action makes it difficult for cancer cells ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced today that it has been selected by the U.S. Department of Energy (DOE), along with three ...